30 likes | 40 Views
The scientific community has tried to address genetic susceptibility and severity to SARS-CoV-2 infection by combining research efforts using existing genetic databases.
E N D
Digital Genome Market Is Thriving Worldwide – BioMérieux, Inscripta Inc., Agilent Technologies Inc., F. Hoffmann-La Roche Ltd. The scientific community has tried to address genetic susceptibility and severity to SARS- CoV-2 infection by combining research efforts using existing genetic databases. Multiomic- based approaches and genome-wide association studies (GWAS) have been employed to uncover biological networks and common variants underlying host-pathogen interactions. Similarly, data derived from genomes, such as polygenic risk scores (PRS), ABO blood groups, and HLA haplotypes, can be potentially used to decipher COVID-19 complications, resistance, and susceptibility. The global Digital Genome market reached ~US$ 12.1 billion in 2021. The market is expected to witness a CAGR of 10% from 2022 to 2030. Prenatal genetic screening programs are likely to grow at a significant pace. This is because these programs help expectant mothers identify chromosomal anomalies in their offspring. Moreover, it is anticipated that in the next 10 years, every newborn’s genome would be sequenced and stored in the electronic medical record. Gauging the future market potential of genomics in newborn screening programs, emerging companies like Counsyl and Natera have launched various genetic tests to maintain their competitive edge in the market. Get a Sample PDF of the Report - https://growthplusreports.com/inquiry/request- sample/digital-genome-market/7910 Key Players •BioMérieux •GenMark Diagnostics, Inc. •Illumina, Inc. •Thermo Fisher Scientific •NanoString Technologies, Inc. •Inscripta Inc. •GE Healthcare Genomic Health, Inc. •Pacific Bioscience, PerkinElmer Inc. •Qiagen Quest Diagnostics •Agilent Technologies Inc. •Becton, Dickinson and Company •F. Hoffmann-La Roche Ltd. •Regeneron Pharmaceuticals, Inc. By Product Type •Sequence & Analysers Instruments •DNA/RNA Analysis kits •Sequencing & Analysis Software •Sample Preparation Instrument
By Application •Microbiology •Reproductive & Genetic •Transplant & Agriculture •Forensics •Research & Development Key Reasons to Purchase: (1)To gain insightful analyses of the market and have a comprehensive understanding of the global market and its commercial landscape. (2)Assess the production processes, major issues, and solutions to mitigate the development risk. (3)To understand the most affecting driving and restraining forces in the Digital Genome Market and its impact in the global market. (4)Learn about the market strategies that are being adopted by leading respective organizations. (5)To understand the outlook and prospects for the market. Key Questions Answered in the Report Include: (1)This report gives all the information about the industry analysis, revenue, and overview, of this market. (2)What will be the rate of increase in market size and growth rate by the end of the forecast period? (3)What are the major global Digital Genome Market trends influencing the development of the market? (4)What are the vital results of SWOT analysis of the major players operating in the Digital Genome Market? (5)What are the potential growth opportunities and threats faced by Major competitors in the market? TOC of Digital Genome Market 1 Scope of the Report 1.1 Market Ecosystem 1.2 Geographic Scope 1.3 Timeline Under Consideration 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered
2 Digital Genome Market Executive Summary 2.1 World Market Overview 2.1.1 Global Market Size 2022-2030 2.1.2 Market Size CAGR by Region 2020 VS 2028 2.2 Digital Genome Market Segment by Type 2.2.1 Type 1 2.2.2 Type 2 Browse the full report now: https://growthplusreports.com/report/digital-genome- market/7910 About us Growth+Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association). Growth+ portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis, and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success. We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.